Short Interest in Atea Pharmaceuticals, Inc (NASDAQ:AVIR) Expands By 7 1% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Stonepine Capital Management LLC boosted its stake in shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) by 9.9% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 752,088 shares of the company’s stock after purchasing an additional 67,580 shares during […]
Atea Pharmaceuticals (NASDAQ:AVIR – Get Free Report) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, November 8th. Analysts expect the company to announce earnings of ($0.46) per share for the quarter. Parties interested in participating in the company’s conference call can do so using this link. Atea Pharmaceuticals […]
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Get Free Report) saw a significant increase in short interest in September. As of September 15th, there was short interest totalling 1,920,000 shares, an increase of 8.5% from the August 31st total of 1,770,000 shares. Currently, 2.6% of the company’s stock are short sold. Based on an average daily trading […]
JPMorgan Chase & Co Downgrades Atea Pharmaceuticals (NASDAQ:AVIR) to Underweight theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.